跳至主要内容
临床试验/CTRI/2024/06/068961
CTRI/2024/06/068961尚未招募2 期

Preclinical & Clinical evaluation Of Safety And Efficacy Of Mehmudgar Vati In The Management Of Madhumeha With Special reference To type 2 diabetes mellitus - NI

ational Institute of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patient ready to give consent for trial and willing to participate in the study
  • 2. Patients between the age group of 30-60 years in either sex.
  • 3. Patients with Fasting Blood Sugar (FBS) in the range of 126mg/dl – 200mg/dl or/and
  • Post Prandial Blood Sugar (PPBS) in the range of 200mg/dl – 250 mg/dl.
  • 4. Newly diagnosed case of Madhumeha (Type 2 diabetes mellitus).
  • 5. Presence of Cardinal symptoms of Diabetes Mellitus eg. (3P- polyuria, polydipsia,
  • polyphagia).

排除标准

  • 1. Patient not willing to sign the consent form.
  • 2. Patients having Type-1 Diabetes Mellitus.
  • 3. Patients of Type -2 Diabetes Mellitus who are on insulin therapy and Drug induced
  • Diabetes Mellitus.
  • 4. DM with complications and Madhumeha with asadhya upadrava.
  • 5. Patients having any serious illness like cardiovascular diseases, renal diseases, hepatic
  • diseases, acute/ chronic pancreatitis, malignancy, any other endocrinopathies .
  • 6. Pregnant and lactating mother.
  • 7. Patient on any other medications which may interfere with the effect of intervention.

研究者

相似试验

Study of Mehmudgar Vati in the management of... | 临床试验